Back

TransXplorer: An automated translational discovery platform for RNA-seq data

Verma, V. M.; Oler, E.; Syed, H.; Han, S.; Berjanskii, M.; Mason, A. L.; Wishart, D. S.; Wong, G. K.-S.

2026-05-16 bioinformatics
10.64898/2026.05.15.724657 bioRxiv
Show abstract

RNA-seq experiments routinely identify thousands of differentially expressed genes, but translating these into biological insights and therapeutic hypotheses often requires integrating multiple tools. Existing web platforms such as iDEP, NetworkAnalyst, and GEPIA2 address individual steps, differential expression, network visualization, or TCGA queries, but lack a unified environment spanning raw data processing to clinical and pharmacological interpretation. TransXplorer (https://transxplorer.org) is a freely available web platform that addresses this limitation by integrating the complete RNA-seq analytical workflow. It supports processing from raw FASTQ files using HISAT2 or Salmon, as well as direct GEO dataset import with automated metadata handling. Differential expression analysis is implemented via DESeq2, edgeR, and limma-voom, followed by functional enrichment across more than 1,800 species using Bioconductor resources. Batch effects are automatically detected and corrected using a composite of PVCA, kBET, and Silhouette metrics without requiring predefined batch annotations. Downstream analyses include co-expression network construction (WGCNA), protein-protein interaction mapping (STRING), cell-type deconvolution, and transcription factor inference using integrated DoRothEA and TFLink resources. The platform further links gene signatures to drug candidates through DGIdb and OpenTargets and enables survival and tumour-normal comparisons across TCGA cohorts. Application to cardiac endothelial differentiation (GSE151427) and kidney renal papillary cell carcinoma (TCGA-KIRP) datasets demonstrates accurate batch correction, biologically consistent pathway enrichment, recovery of expected cell-type proportions, and identification of clinically relevant genes and drug candidates. TransXplorer is freely available without a login.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Bioinformatics
1061 papers in training set
Top 2%
16.9%
2
Nucleic Acids Research
1128 papers in training set
Top 1%
13.8%
3
Nature Methods
336 papers in training set
Top 1%
8.1%
4
Genome Biology
555 papers in training set
Top 1.0%
6.6%
5
Nature Biotechnology
147 papers in training set
Top 2%
6.1%
50% of probability mass above
6
Bioinformatics Advances
184 papers in training set
Top 0.6%
6.1%
7
Nature Communications
4913 papers in training set
Top 35%
4.7%
8
Genome Medicine
154 papers in training set
Top 2%
4.0%
9
BMC Bioinformatics
383 papers in training set
Top 3%
3.5%
10
Briefings in Bioinformatics
326 papers in training set
Top 2%
3.5%
11
NAR Genomics and Bioinformatics
214 papers in training set
Top 0.8%
3.5%
12
PLOS ONE
4510 papers in training set
Top 44%
2.6%
13
GigaScience
172 papers in training set
Top 2%
1.6%
14
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 4%
1.3%
15
Scientific Reports
3102 papers in training set
Top 67%
1.2%
16
Genome Research
409 papers in training set
Top 3%
1.1%
17
Cell Systems
167 papers in training set
Top 10%
0.9%
18
PLOS Computational Biology
1633 papers in training set
Top 23%
0.9%
19
Patterns
70 papers in training set
Top 3%
0.7%
20
Advanced Science
249 papers in training set
Top 23%
0.6%
21
Nature
575 papers in training set
Top 18%
0.6%
22
NAR Cancer
36 papers in training set
Top 0.2%
0.6%
23
Nature Genetics
240 papers in training set
Top 9%
0.6%